Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

Article English OPEN
Catto, J. W. F.; Robinson, M. C.; Albertsen, P. C.; Goepel, J. R.; Abbod, M. F.; Linkens, D. A.; Davis, M.; Rosario, D. J.; Warren, A. Y.; Varma, M.; Griffiths, D. F.; Grigor, K. M.; Mayer, N. J.; Oxley, J. D.; Deshmukh, N. S.; Lane, J. A.; Metcalfe, C.; Donovan, J. L.; Neal, D. E.; Hamdy, F. C.; ProtecT Study Grp, P. S. G.;
(2011)
  • Publisher: Cancer Research UK

background: Contemporary screening for prostate cancer frequently identifies small volume, low-grade lesions. Some clinicians have advocated focal prostatic ablation as an alternative to more aggressive interventions to manage these lesions. To identify which patients m... View more
  • References (24)
    24 references, page 1 of 3

    Catto JW, Abbod MF, Linkens DA, Larre S, Rosario DJ, Hamdy FC (2009) Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Clin Cancer Res 15: 3150 - 3155

    Challacombe BJ, Murphy DG, Zakri R, Cahill DJ (2009) High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. BJU Int 104: 200 - 204

    Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P (2003) A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 27: 1291 - 1301

    Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO (2005) Preoperative prediction of small volume cancer (less than 0.5ml) in radical prostatectomy specimens. J Urol 174: 898 - 902

    Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178: S14 - S19

    Denberg TD, Melhado TV, Steiner JF (2006) Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer 107: 620 - 630

    Djavan B, Susani M, Bursa B, Basharkhah A, Simak R, Marberger M (1999) Predictability and significance of multifocal prostate cancer in radical prostatectomy specimen. Tech Urol 5: 139 - 142

    Donovan J, Hamdy F, Neal D, Peters T, Oliver S, Brindle L, Jewell D, Powell P, Gillatt D, Dedman D, Mills N, Smith M, Noble S, Lane A (2003) Prostate testing for cancer and treatment (ProtecT) feasibility study. Health Technology Assessment (Winchester, England) 7: 1 - 88

    Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L (2007) Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178: 2260 - 2267

    Eichelberger LE, Cheng L (2004) Does T2b prostate cancrinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. Cancer 100: 2573 - 2576

  • Similar Research Results (1)
  • Related Organizations (31)
  • Metrics
Share - Bookmark